696 related articles for article (PubMed ID: 26059477)
1. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
Shamim A; Abbasi SW; Azam SS
J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
[TBL] [Abstract][Full Text] [Related]
2. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production.
Misra N; Patra MC; Panda PK; Sukla LB; Mishra BK
J Biomol Struct Dyn; 2013 Mar; 31(3):241-57. PubMed ID: 22830394
[TBL] [Abstract][Full Text] [Related]
3. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
Song H; Ao GZ; Li HQ
Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428
[TBL] [Abstract][Full Text] [Related]
4. PqsBC, a Condensing Enzyme in the Biosynthesis of the Pseudomonas aeruginosa Quinolone Signal: CRYSTAL STRUCTURE, INHIBITION, AND REACTION MECHANISM.
Drees SL; Li C; Prasetya F; Saleem M; Dreveny I; Williams P; Hennecke U; Emsley J; Fetzner S
J Biol Chem; 2016 Mar; 291(13):6610-24. PubMed ID: 26811339
[TBL] [Abstract][Full Text] [Related]
5. Refined structures of beta-ketoacyl-acyl carrier protein synthase III.
Qiu X; Janson CA; Smith WW; Head M; Lonsdale J; Konstantinidis AK
J Mol Biol; 2001 Mar; 307(1):341-56. PubMed ID: 11243824
[TBL] [Abstract][Full Text] [Related]
6. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Ashek A; Cho SJ
Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
[TBL] [Abstract][Full Text] [Related]
7. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
Zhou Y; Du QR; Sun J; Li JR; Fang F; Li DD; Qian Y; Gong HB; Zhao J; Zhu HL
ChemMedChem; 2013 Mar; 8(3):433-41. PubMed ID: 23401291
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A.
Musayev F; Sachdeva S; Scarsdale JN; Reynolds KA; Wright HT
J Mol Biol; 2005 Mar; 346(5):1313-21. PubMed ID: 15713483
[TBL] [Abstract][Full Text] [Related]
9. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
Fernandes TB; Segretti ND; Lourenço FR; Cândido TM; Baby AR; Barbosa EG; Parise-Filho R
Med Chem; 2021; 17(5):474-484. PubMed ID: 31763975
[TBL] [Abstract][Full Text] [Related]
10. Structural Characterisation of the Beta-Ketoacyl-Acyl Carrier Protein Synthases, FabF and FabH, of Yersinia pestis.
Nanson JD; Himiari Z; Swarbrick CM; Forwood JK
Sci Rep; 2015 Oct; 5():14797. PubMed ID: 26469877
[TBL] [Abstract][Full Text] [Related]
11. Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae beta-ketoacyl-acyl carrier protein synthase III (FabH).
Khandekar SS; Gentry DR; Van Aller GS; Warren P; Xiang H; Silverman C; Doyle ML; Chambers PA; Konstantinidis AK; Brandt M; Daines RA; Lonsdale JT
J Biol Chem; 2001 Aug; 276(32):30024-30. PubMed ID: 11375394
[TBL] [Abstract][Full Text] [Related]
12. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Li HQ; Luo Y; Zhu HL
Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure and substrate specificity of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
Qiu X; Choudhry AE; Janson CA; Grooms M; Daines RA; Lonsdale JT; Khandekar SS
Protein Sci; 2005 Aug; 14(8):2087-94. PubMed ID: 15987898
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies.
Ramamoorthy D; Turos E; Guida WC
J Chem Inf Model; 2013 May; 53(5):1138-56. PubMed ID: 23581389
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
[TBL] [Abstract][Full Text] [Related]
17. Identification and analysis of the acyl carrier protein (ACP) docking site on beta-ketoacyl-ACP synthase III.
Zhang YM; Rao MS; Heath RJ; Price AC; Olson AJ; Rock CO; White SW
J Biol Chem; 2001 Mar; 276(11):8231-8. PubMed ID: 11078736
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial FabH Inhibitors with Mode of Action Validated in Haemophilus influenzae by in Vitro Resistance Mutation Mapping.
McKinney DC; Eyermann CJ; Gu RF; Hu J; Kazmirski SL; Lahiri SD; McKenzie AR; Shapiro AB; Breault G
ACS Infect Dis; 2016 Jul; 2(7):456-64. PubMed ID: 27626097
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of beta-ketoacyl-acyl carrier protein synthase II from Synechocystis sp. at 1.54 A resolution and its relationship to other condensing enzymes.
Moche M; Dehesh K; Edwards P; Lindqvist Y
J Mol Biol; 2001 Jan; 305(3):491-503. PubMed ID: 11152607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
